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As the final segment of the nephron, the collecting duct is the
ultimate regulator of renal salt and water excretion. Balance
between intake and renal excretion of salt and water is fine-
tuned by the action of several hormones targeted to the collect-
ing duct. Vasopressin is, perhaps, the prototypical example of
such a hormone. As total body water decreases and plasma
osmolality rises, vasopressin secretion from the posterior pitu-
itary increases [1]. Picomolar concentrations of circulating
vasopressin lead to increased water permeability of the apical
membrane of the collecting duct cell, resulting in increased
water reabsorption and increased total body water [2, 3]. There
is abundant evidence demonstrating that vasopressin's effect on
water reabsorption in the collecting duct is mediated through
the classic second messenger, cAMP [3]. V2 selective receptors
are linked via a G protein, to stimulation of plasma membrane
adenylyl cyclase, resulting in increased cell cyclic AMP levels
[4, 5]. The increased cyclic AMP then leads to augmented water
permeability of the apical membrane [6, 7].
As one might expect with such an important biologic process,
other hormones and autocoids provide a counter-regulatory
influence to modulate vasopressin mediated increases in os-
motic water permeability. There is good evidence that the
arachadonic acid metabolite, prostaglandin E, (PGE,) plays a
critical physiologic and pathophysiologic role in inhibiting vaso-
pressin action in the collecting duct [8, 9]. Not only is the
collecting duct the major renal site of synthesis for this cyclo-
oxygenase product of arachidonic acid but PGE2 production is
stimulated by vasopressin itself [10—12]. PGE2 infusion signifi-
cantly blunts water reabsorption and cycloxygenase inhibition
augments vasopressin antidiuresis [9, 13]. Thus, there is good
evidence that the autocoid POE2 plays an important role in
regulating vasopressin-stimulated osmotic water flow.
Cellular effects of exogenous prostaglandin E2
The cellular mechanisms by which PGE2 inhibits vasopres-
sin-stimulated osmotic water flow have been extensively exam-
ined both in functional studies using isolated perfused cortical
collecting ducts, and in biochemical studies measuring cyclic
AMP generation in isolated collecting duct cells. Isolated per-
fused tubule studies have documented both stimulatory and
inhibitory effects of the PGE series on transepithelial water
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flow. In pioneering studies by Grantham and Orloff, POEI alone
increased osmotic water permeability but when added to tu-
bules pretreated with vasopressin, PGEI blunted osmotic water
flow [8]. This observation recently has been confirmed and
extended by Nadler, Hebert and Brenner [14] who showed that
i0 mol PGE2 increased osmotic water flow in rabbit cortical
collecting ducts, while PGE2 blunted vasopressin action when
the two agents were used together. In contrast, in forskolin or
3'S' cyclic AMP pretreated collecting ducts no inhibitory effect
of PGE2 or PGE1 on osmotic water flow was seen. These
functional studies suggest that PGE2 decreases vasopressin
stimulated water flow by interfering with cyclic AMP genera-
tion and does not inhibit water flow at steps occurring after
cyclic AMP generation.
Biochemical studies confirm PGE2's capacity to modulate
cell cyclic AMP levels via both stimulatory and inhibitory
pathways. Chabardes et al [15] showed that PGE2 decreased
cyclic AMP production in microdissected rabbit cortical col-
lecting ducts, while Torakai and Kurokawa [16] found that
PGE, suppressed cyclic AMP accumulation in the rat cortical
collecting duct. Sonnenburg and Smith [17] showed in immun-
odissected rabbit collecting duct cells that PGE2 both inhibited
AVP stimulated cyclic AMP accumulation and in higher con-
centrations, stimulated cyclic AMP accumulation by itself. The
inhibitory effect of PGE2 on vasopressin-stimulated cyclic AMP
production was reversed by pertussis toxin pretreatment. These
results suggest POE2 down-modulates vasopressin-stimulated
cyclic AMP accumulation via a pertussis toxin-sensitive gua-
nine nucleotide binding protein (Gi) [18]. Thus biochemical
studies suggest that pertussis toxin pretreatment should reverse
the inhibitory effect of POE2 on vasopressin-induced water
flow.
While a role for the direct interaction of PGE2 receptors with
inhibitory and stimulatory guanine nucleotide regulatory pro-
teins is one explanation for the water permeability effects of
POE2, other potential mechanisms of action remain unex-
plored. Several recent reports have demonstrated that PGE2
can increase intracellular calcium in MDCK cells [19], bovine
adrenal chromaffin cells [20], and the osteoblast cell line UMR-
106 [21]. In these cells, it was demonstrated that PGE2 in-
creases inositol trisphosphate production, presumably by acti-
vation of phosphatidylinositol hydrolysis. Since diacylglycerols
are formed together with inositol phosphates [22, 23] one would
also expect that protein kinase-C is activated when these cells
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Minutes post AVP
Fig. 1. The protein kinase-C inhibitor, slaurospo,'ine, ;'ei'e,'scs inhibi-
tion of vasopressin-stimulated u'aler permeability hr PGE2. CCD's
were perfused 37°C in the presence or absence of staurosporine
pretreatment(107 M). Ten 1dM AVP was added at time zero. After 45
minutes of vasopressin, PGE, IO M was added. Lightly stippled line
represent time control L. solid lines represent PGE, treated tubules.
L dashed line represents staurosporine pretreated tubules with vaso-
pressin plus PGE2. Error bars represent SE. (Used with permission
from [27]).
are exposed to PGE2. In this regard, it is significant to note that
increased intracellular calcium and protein kinase-C activation
not only regulate cyclic AMP generation in several cell types,
including the collecting duct, but also modulate vasopressin-
stimulated water flow at steps distal to cyclic AMP generation
[23—261. Thus, it is conceivable that PIP2 breakdown is a
biochemical signal mediating the inhibitory effects of PGE2 on
vasopressin-stimulated osmotic water flow. We tested this
possibility in isolated perfused rabbit cortical collecting ducts
[271.
Isolated perfused tubule studies made use of two general
techniques. First, hydraulic conductivity (Lv) was measured
using a 150 mOsm perfusate and 300 mOsm bath. Tritiated
inulin was present in the perfusate. The increase in cpm/nl due
to water flow out of the lumen can be directly converted to
hydraulic conductivity (L0) according to Dubois, Verniory and
Abramow [28]. Other studies used fura-2 loaded rabbit cortical
collecting ducts to measure intracellular calcium. While the
majority of previously published studies regarding the action of
POE2 on water flow in the collecting duct have examined its
effects at room temperature, the present studies examined the
effects of PGE2 at the physiologic temperature of 37°C.
Preliminary studies confirmed that when PGE, was adminis-
tered to tubules pretreated with vasopressin, AVP-stimulated
osmotic water flow was markedly inhibited with L falling from
192.5 20 (AVP 10 U/ml alone) to a mean of 91.5 14.1 (10
piM AVP plus l0- M PGE2; Fig. I). Of note, control L0 was
very stable at 37°C in contrast with earlier reports demonstrat-
ing a time-dependent decrease in the L response to vasopres-
sin in the rabbit [29]. A stable L has now been observed in at
least two other laboratories [30, JS Schafer, personal commu-
I
Minutes post AVP
Fig. 2. Pe,'tussis toxin blocks the inhibitory action of PGE, on vaso-
pressin—stimulated osmotic water permeability in rabbit cortical collect-
ing ducts. Isolated perfused rabbit CCD's (37°C) were treated with 10
piM AVP at time zero. Time controls for pertussis toxin-treated tubules
are solid black lines and squares. Pertussis toxin treated tubule exposed
to PGE, are solid lines, no symbol, and the POE, controls in nonper-
tussis toxin-treated tubules are in the open squares.
nication]. While the precise reasons for these differences re-
mains to be determined, this stability permits a demonstration
of the clearcut decline in osmotic water flow due to POE2 at
physiologic temperatures.
Other studies were performed examining the effect of PGE2
on cAMP-stimulated osmotic water flow. For these studies we
used the phosphodiesterase resistant, cell permeable analogue,
8 chlorophenythio-cAMP, (8-CPT cAMP). 8-CPT cAMP, 0.1
m, increased L0 from 10 2.0 to 182.2 22. Addition of iO
PGE, to 8-CPT cAMP failed to inhibit, and resulted in a slight
increase in water permeability to 215 6 32.8 (N = 6, P =
NS). These studies document that once water flow is estab-
lished, the inhibitory effect of PGE, on osmotic water flow
occurs by altered cell cAMP levels, since when cell cAMP
levels are maintained by the exogenous cell permeable cAMP
analogue, no effect of POE2 on water flow is seen. Thus PGE2
inhibits vasopressin induced water flow at a pre-cAMP step.
To determine whether a pertussis toxin sensitive, inhibitory
G-protein (Gi) could be functionally demonstrated [31], collect-
ing ducts were pretreated with 500 nglml pertussis toxin for one
hour. CCDs were then exposed to vasopressin followed by
PGE,. Pertussis toxin pretreatment blocked POE2 inhibition of
AVP stimulated water flow (Fig. 2). These results are consistent
with biochemical studies that pertussis toxin blocks PGE2
inhibition of vasopressin-stimulated cAMP accumulation in
collecting duct cells [17]. Thus, both biochemical and functional
studies suggest a role for a pertussis toxin-sensitive process
mediating the inhibitory effect of PGE2 on water permeability.
It was of particular interest to us that while pertussis toxin
blocked PGE,'s capacity to inhibit vasopressin-stimulated os-
motic water flow, we saw no effect on PGE2's capacity to
depolarize the spontaneous lumen-negative transepithelial volt-
age in the collecting duct [32]. It is well demonstrated in the
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Fig. 3. PGE2 increases intracellular calciu,n in isolated pe,fused rab-
bit cortical collecting ducts. Upper panel shows the effect of lO and10 M PGE2 on isolated perfused rabbit CCD in the precence of
extracellular calcium. The lower panel depicts the effect of l0- M
PGE2 on intracellular calcium bathed in the absence of extracellular
calcium. In the presence of extracellular calcium, PGE, caused an
abrupt increase followed by a smaller but sustained elevation in
intracellular calcium. In the absence of extracellular calcium, PGE,
caused an abrupt increase in intracellular calcium but then calcium fell
to basal levels. This shows POE, releases calcium from intracellular
stores. (Used with permission from [27]).
rabbit collecting duct that PGE, inhibits active sodium trans-
port and that this is associated with a positive deflection in Vt.
While the mechanism of this PGE2 effect on sodium transport is
unknown, it appears to be distinct from the pertussis toxin-
sensitive effect on water transport. Thus it was clear that when
Gi was blocked by pertussis toxin, and Gs activated by vaso-
pressin, POE2 induced depolarization represented a third, sep-
arate functional effect of PGE2 on the collecting duct. Since
studies in other cell types had suggested that POE2 can activate
phosphatidylinositol hydrolysis [19—21], we examined the ca-
pacity of PGE2 to increase intracellular calcium in the rabbit
collecting duct.
As depicted in Figure 3, PGE2 produced a prompt increase in
cytosolic Ca in the rabbit cortical collecting duct. Intracel-
lular Ca rose to 356 52% of basal levels. This was followed
by a gradual decline in intracellular calcium and stabilization at
a value 52% above basal calcium. Other studies performed in
the absence of extracellular calcium documented that POE,
raises intracellular calcium by a mechanism involving the
release of calcium from intracellular stores (Fig. 3). Since a
portion of the calcium release is from intracellular stores, these
data suggest that PGE2 might stimulate production of inositol
trisphosphate and diacylglycerol. If diacylglycerol is produced
then one would expect that PGE2 would activate protein
kinase-C in the collecting duct [23].
Our earlier studies had suggested that protein kinase-C acti-
vation can inhibit osmotic water flow in the collecting duct [251.
We therefore next tested the effect of the protein kinase-C
inhibitor staurosporine [33, 34] on POE2 mediated inhibition of
vasopressin-stimulated water flow. CCDs were pretreated with
staurosporine and then exposed to vasopressin followed by
vasopressin plus PGE, l0 M. As can be seen in Figure 4,
staurosporine blocked the inhibitory effect of PGE2 on vaso-
pressin-stimulated osmotic water flow. Thus, not only does
POE2 raise intracellular calcium in the collecting duct, but there
is also evidence for protein kinase-C activation by PGE2.
Several studies have examined the role of protein kinase-C
activation in vasopressin action in the collecting duct. Biochem-
ical studies have suggested that protein kinase-C activation can
down-modulate vasopressin-stimulated cAMP accumulation in
cultured rabbit collecting duct cells [24]. Similarly studies in the
toad bladder suggest that PKC activation can inhibit osmotic
water flow at both pre- and post-cAMP generation sites [33].
Indeed, our earlier studies showed that pretreatment of collect-
ing ducts with phorbol myristate acetate or diacyclglycerols
potently inhibited both vasopressin and 8-CPT cAMP stimu-
lated osmotic water flow, suggesting PKC activation can inhibit
water flow at a site distal to cAMP generation [25]. Since
previous studies only examined the effect of POE2 addition
after vasopressin [8, 14], we tested the effect of PGE2 pretreat-
ment on both vasopressin and 8-CPT cAMP-stimulated osmotic
water flow [27]. By itself, POE2 increases osmotic water
permeability in the rabbit collecting duct from a basal of 10.3
1,4 to a mean of 56.4 6.8 cm/(atm. sec). Subsequent addition
of either vasopressin or 8-CPT cAMP (in the continued pres-
ence PGE2) resulted in markedly reduced osmotic water flow as
compared with tubules not pretreated with POE2 (Fig. 4). These
studies demonstrate that the mechanism by which PGE2 pre-
treatment inhibits osmotic water flow is markedly different than
the effect of POE, after osmotic water flow is first established.
When POE2 is added first, it inhibits osmotic water flow at a
post cAMP step. If AVP or cAMP is added first, followed by
POE2, only AVP-induced water permeability is inhibited, These
effects of POE2 pretreatment were therefore consistent with our
earlier studies showing a post-cAMP effect of protein kinase-C
activation [25].
We next tested whether the protein kinase-C inhibitor, stau-
rosporine, blocked PGE2 inhibition of cAMP-stimulated os-
motic water flow. When CCD's were pretreated with stauro-
sporine, not only was the inhibitory effect of POE2 on 8-CPT
cAMP-induced osmotic water permeability markedly attenu-
ated, but the effect of POE2 alone on osmotic water permeabil-
ity was markedly augmented, yielding a mean L of 56 in
non-staurosporine pretreated controls to 141.9 24.9 in the
staurosporine treated CCD (Fig. 4). This result is consistent
with the simultaneous activation of two separate and opposing
signal transduction pathways. Thus, when staurosporine is
present the inhibitory pathway is blocked, and a dominant
stimulatory effect of POE, on osmotic water permeability is
seen.
The differences between the mechanisms by which POE2
inhibits osmotic water flow when applied before or after vaso-
pressin deserves further comment. In the latter case PGE2
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Fig. 4. PGE2 pretreatment inhibits cAMP stimulated waler permeabil-
ity. Isolated perfused collecting ducts were pretreated with POE, and
subsequently exposed to 0.1 mt 8-CPT cAMP. By itself PGE, signifi-
cantly increased L (darkly stippled column). Subsequent exposure to
cAMP revealed marked suppression of hydaulic conductivity (striped
column) as compared with 0.1 msi 8-CPT controls (lightly stippled
column). Pretreatment of CCD's l0- M staurosporin caused marked
augmentation in L response to lO M POE, alone (right hand column,
darkly stippled). Subsequent exposure to cAMP revealed affirmation of
POE2 inhibition of cAMP stimulated L. (Used with permission from
[27]).
interferes with a post-cyclic AMP effect of vasopressin,
whereas when administered after vasopressin, POE, appears to
block cyclic AMP generation, but does not interfere with cyclic
AMP-stimulated water flow. This highlights the difference be-
tween the mechanisms involved in the onset of osmotic water
flow in the collecting duct and those responsible for the main-
tenance of osmotic water flow. Clearly, there must be some
cellular event(s) involved in the insertion of water permeable
membrane in the collecting duct which is not required for the
maintenance of osmotic water flow, and which can be blocked
by PGE2.
Role of endogenous PGE2
It is of interest to consider how these effects of exogenous
PGE2 relate to the effects of endogenous cyclooxygenase
metabolites on collecting duct function. As alluded to earlier,
both biochemical and whole animal studies suggest that vaso-
pressin stimulates endogenous prostaglandin synthesis and this
significantly blunts the hydroosmotic response to vasopressin.
Thus Anderson et al [9] have demonstrated that indomethacin
pretreatment of steroid replaced hypophysectomized dogs un-
dergoing a water diuresis resulted in a significant augmentation
of urinary concentration in response to a fixed dose of AVP.
Since no effect of indomethacin on either systemic or intrarenal
hemodynamics was observed, these results suggest a direct
effect of endogenous prostaglandins to antagonize the antidi-
uretic action of vasopressin. Similar results were obtained by
Fejes-Toth, Magyar and Walter [13]. Although there were some
hemodynamic changes noted, they did not appear to correlate
with the results on vasopressin induced diuresis.
In agreement with a potential role for intrarenal prostaglan-
dins interfering with vasopressin's action are studies which
document that the collecting duct is not only a major site of
PGE, synthesis, but that vasopressin itself stimulates prosta-
glandin synthesis in isolated collecting ducts [10—12]. Several
investigators have shown in cultured and microdissected col-
lecting ducts that nanomolar to micromolar vasopressin in-
creases PGE, synthesis. Recently investigators have examined
the effects of V, selective analogues on prostaglandin synthesis
by the collecting duct. The results are mixed: while some
investigators show no effect of DDAVP on rabbit cortical
collecting duct or cultured rat inner medullary collecting duct
[35—36], other investigators have found DDAVP potently sum-
ulates prostaglandin synthesis in the collecting duct [11, 371.
Thus it remains unclear whether V2 receptors mediate vaso-
pressin-stimulated prostaglandin synthesis or whether V1 [38],
oxytocin [39], or some other receptor mediates this effect.
Despite evidence for vasopressin-stimulated PGE2 synthesis,
no clear-cut inhibitory effect of endogenous prostaglandin syn-
thesis on vasopressin stimulated water flow can be demon-
strated in the isolated perfused cortical collecting duct. Thus,
neither Stokes [40], Schuster [41] or Ando, Breyer and Jacob-
son [42] were able to demonstrate augmentation of vasopressin-
stimulated osmotic water flow with cyclooxygenase inhibition
by meclofenamate, naproxyn, ibuprofen or indomethacin. The
studies of Ando et al [42], however, compared the effect of
indomethacin pretreatment on 23 ptvt, 230 M and 23 nM, These
studies showed indomethacin pretreatment significantly aug-
mented the capacity of 23 nM vasopressin to increase Osmotic
water permeability (Fig. 5). In fact, in the absence of cyclooxy-
genase blockade, the dose response to vasopressin demon-
strated a fall off in the L effect of 23 nM AVP versus 230
picomoler AVP. However, in the setting of cyclooxygenase
inhibition the hydroosmotic effect of 230 pmol and 23 nmol were
equal (Fig. 5). From these studies it would seem that endoge-
nous cyclooxygenase products significantly inhibit vasopressin-
stimulated water permeability only when very high concentra-
tions of vasopressin are used, and that lower vasopressin
concentrations do not autoinhibit water permeability via endog-
enous prostaglandin synthesis in the isolated perfused CCD.
It is also important to note that 23 nM vasopressin resulted in
a significant increase in intracellular calcium, whereas 230 pmol
vasopressin produced only a small increase in intracellular
calcium. Since increased cell calcium is most typically associ-
ated with that of a V1 [391 or oxytocin receptor [39, 43] and not
a V. receptor [44], it is conceivable that vasopressin-stimulated
arachidonate release and prostaglandin synthesis may be due to
a V1 like effect and not be associated with a classic V2 effect.
Indeed there is evidence that the release of arachadonate
leading to increased prostaglandin synthesis may directly result
from increased cytosolic calcium. Thus Schlondorff, Satriano
and Schwartz [12] demonstrated that the calcium ionophore,
ionomycin, was a highly potent stimulus to prostaglandin syn-
thesis in both cortical and medually collecting ducts. These
results are in good agreement with those of Craven and
DeRubertsis [45], who showed the calcium ionophore A234 187,
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Fig. 5. The effect cyclooxygenase blockade on vasopressin-stimulated
osmotic water permeability dose response relationship. Controlled
tubules (lightly stippled bars) demonstrate that at 23 nM AVP stimulated
water permeability is less at 230 M (t = P < 0.05) indomethacin
pretreatment (5 /.tM) failed to effect osmotic water permeability stimu-
lated by AVP at either 23 M or 230 psi, however, indomethacin
pretreatment markedly stimulated water permeability at 23 nM AVP (*
= P < 0.01). (Adapted from [421).
stimulated arachidonate, diglyceride, prostaglandin E2 and
prostaglandin F2 release from medullary slices of rat kidney.
Water flux studies also suggest that calcium ionophores
stimulate endogenous production of cyclooxygenase metabo-
lites and thereby inhibit water flow. Ando, Jacobson and Breyer
[34], showed that low concentrations of A23 187 (20/rmol)
potently inhibited vasopressin-induced osmotic water flow, but
that this inhibition was markedly attenuated by pretreatment
with 5 jimol indomethacin or removal of bath calcium. Similar
results were obtained by Jones, Frindt and Windhager [26] who
found that the calcium ionophore ionomycin inhibited water
permeability, and that it was reversed by the cyclooxygenase
inhibitor ibuprofen. Theses studies would then suggest that
increased intracellular calcium stimulates cyclooxygenase
products, and thereby inhibits vasopressin-induced osmotic
water flow. Whether agonist induced increases in intracellular
calcium have a similar direct effect on prostaglandin synthesis
remains to be determined. However, it is interesting that
nanomolar vasopressin increases intracellular calcium and also
increases POE2 synthesis in the collecting duct.
In this regard how should we consider the effects of exoge-
nous PGE2 on intracellular calcium? Does PGE2 signalling
constitute a positive feedback mechanism, whereby POE2
raises intracellular calcium, stimulating more arachadonate
release and prostaglandin synthesis, leading to more intracellu-
lar calcium release? While we have not directly examined the
effects of cyclooxygenase inhibition on agonist induces calcium
release, it is clear that indomethacin pretreatment itself does
not alter the capacity of PGE2 to inhibit vasopressin-induced
osmotic water permeability. Thus, in collecting ducts pre-
treated with 5 m indomethacin, POE2 still resulted in a potent
inhibition of osmotic water permeability (Fig. 6). Thus it seems
unlikely that the calcium increase induced by exogenous PGE2
inhibits water permeability by stimulation of endogenous cyl-
cooxygenase products. It remains to be shown that endogenous
prostaglandins are capable of releasing calcium from intracel-
lular stores or stimulating 1P3 release. External plasma mem-
brane receptors for prostaglandin E2 may mediate effects quite
Fig. 6. Indomethacin pretreatment fails to affect PGE2 inhibition of
vasopressin-induced osmotic water flow. These studies were designed
to determine whether PGE2 mediated increase in intracellular calcium
could stimulate endogenous cyclooxygenase products and thereby
inhibit vasopressin-induced water permeability. Symbols are: (0)
AVP; (0) AVP + PGE2. Left hand columns are controls and right hand
columns are tubules pretreated with 5 M indomethacin. Pretreatment
with 5 jsi indomethacin failed to affect PGE2 inhibition of osmotic
water permeability (unpublished results).
different from those available to endogenously produced pros-
taglandins.
In summary, there is now good evidence that exogenous
prostaglandin E2 can interact with at least three different
signalling pathways in the rabbit cortical collecting duct (Fig.
7). Two of these pathways couple to adenylyl cyclase, one
resulting in increased collecting duct cAMP and water flow and
the other, pertussis sensitive, down-modulating cyclic AMP
accumulation and water flow. It seems likely that these effects
are mediated through prostaglandin E2 receptors coupled to
adenylyl cyclase through Os and Gi, The third and newest
observation is that prostaglandin E2 can also release calcium
from intracellular stores in the collecting duct and PGE2's
effects on water flow can be reversed by a protein kinase-C
inhibitor (staurosporine). These observations suggest that pros-
taglandin E2 may stimulate phosphatidylinositol hydrolysis in
the rabbit cortical collecting duct. In agreement with evidence
suggesting POE2 does not simply modulate cAMP generation, is
the observation that pretreatment of collecting ducts with
prostaglandin E2 results in inhibition of both vasopressin and
8-CPT cAMP-stimulated osmotic water flow, documenting for
the first time a post-cAMP site of inhibition by PGE2.
Based on these observations as well as those of others the
effects of PGE2 on water permeability in the collecting duct can
be fit to a triple effector model with POE2 receptors coupled to
three signalling pathways via specific G protein (Fig. 7): Gs, Gi
and Gp. It remains to be proven that separate POE2 receptors
mediate these different effects, but there is suggestive evidence
that this may be the case [17]. It may also turn out that the
newly described effect of PGE2 to raise intracellular calcium in
the collecting duct will have important implications for cation
transport as well as for water flow. Indeed, preliminary obser-
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Fig. 7. Triple effector model for PGE2 effects in the collecting duct.
Model 4 depicts the potential interactions of POE, with intracellular
signal transduction mechanisms in the rabbit cortical collecting duct. RI
shows PGE2's capacity to increase cAMP and osmotic water perme-
ability, R2 depicts pertussis toxin-sensitive capacity of POE, to inhibit
vasopressin-stimulated osmotic water flow and cAMP accumulation,
R3 depicts POE2 staurosporin sensitive inhibition of both vasopressin
and 8-CPT cAMP stimulated osmotic water flow as well as PGE's
capacity to increase intracellular calcium in rabbit cortical collecting
duct.
vations suggest that this is the case 46]. Whether endogenous
prostaglandin synthesis activates the same signalling mecha-
nisms, or has different effects remains to be determined.
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